FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Medical Park Loipl
Industry / private company
Location:
Bischofswiesen, Germany (DE)
Publications
(7)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
The association of upper limb sensorimotor capacity, everyday inpatient behavior, and the effects of neurorehabilitation in persons with multiple sclerosis and stroke: a mixed-design study (2025)
Gulde P, Vojta H, Schmidle S, Rieckmann P, Hermsdörfer J
Journal article
Outside the Laboratory Assessment of Upper Limb Laterality in Patients With Stroke: A Cross-Sectional Study (2024)
Gulde P, Vojta H, Schmidle S, Rieckmann P, Hermsdörfer J
Journal article
Going beyond PA: Assessing sensorimotor capacity with wearables in multiple sclerosis-a cross-sectional study (2023)
Gulde P, Vojta H, Schmidle S, Rieckmann P, Hermsdörfer J
Journal article
Can Growth Hormone Lead to a Faster Recovery from Guillain-Barré Syndrome? Case Report of the First Therapeutic Use in One Patient (2023)
Amereller F, Schopohl J, Störmann S, Schilbach K, Bidlingmaier M, Fischer M, Rieckmann P, Gulde P
Journal article
Expert opinion on COVID-19 vaccines and cladribine tablets in MS: A plain language summary. (2023)
Rieckmann P, Centonze D, Giovannoni G, Hua LH, Oreja-Guevara C, Selchen D, Sorensen PS, et al.
Journal article, Review article
Sensorimotor function does not predict quality of life in persons with multiple sclerosis (2021)
Gulde P, Hermsdörfer J, Rieckmann P
Journal article
Benefit-risk Assessment of Cladribine Using Multi-criteria Decision Analysis (MCDA) for Patients With Relapsing-remitting Multiple Sclerosis (2019)
Vermersch P, Martinelli V, Pfleger C, Rieckmann P, Alonso-Magdalena L, Galazka A, Dangond F, Phillips L
Journal article